Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.2479 | 77 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.31835 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.34835 | 78 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.51132 | 78 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.36721 | 78 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.30412 | 79 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.52014 | 80 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.31042 | 78 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.31447 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.40101 | 78 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.53274 | 79 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.40911 | 78 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.32625 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.33857 | 78 |